NASDAQ:CDLX Cardlytics (CDLX) Stock Price, News & Analysis $1.18 -0.12 (-9.23%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.20 +0.03 (+2.12%) As of 08/8/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Cardlytics Stock (NASDAQ:CDLX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cardlytics alerts:Sign Up Key Stats Today's Range$1.17▼$1.3150-Day Range$1.18▼$3.1252-Week Range$1.17▼$5.25Volume2.00 million shsAverage Volume2.13 million shsMarket Capitalization$62.82 millionP/E RatioN/ADividend YieldN/APrice Target$3.25Consensus RatingHold Company Overview Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Read More Cardlytics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScoreCDLX MarketRank™: Cardlytics scored higher than 66% of companies evaluated by MarketBeat, and ranked 113th out of 306 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingCardlytics has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no buy ratings, 5 hold ratings, and 1 sell rating.Amount of Analyst CoverageCardlytics has only been the subject of 1 research reports in the past 90 days.Read more about Cardlytics' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardlytics is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardlytics is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardlytics has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted12.06% of the outstanding shares of Cardlytics have been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in Cardlytics has recently decreased by 13.71%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCardlytics does not currently pay a dividend.Dividend GrowthCardlytics does not have a long track record of dividend growth. Sustainability and ESG2.8 / 5Environmental Score-0.67 Percentage of Shares Shorted12.06% of the outstanding shares of Cardlytics have been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in Cardlytics has recently decreased by 13.71%, indicating that investor sentiment is improving significantly. News and Social Media0.9 / 5News Sentiment-0.43 News SentimentCardlytics has a news sentiment score of -0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Cardlytics this week, compared to 5 articles on an average week.Search InterestOnly 4 people have searched for CDLX on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $34,390.00 in company stock.Percentage Held by InsidersOnly 4.40% of the stock of Cardlytics is held by insiders.Percentage Held by Institutions68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cardlytics' insider trading history. Receive CDLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter. Email Address CDLX Stock News HeadlinesUS$2.10: That's What Analysts Think Cardlytics, Inc. (NASDAQ:CDLX) Is Worth After Its Latest Results1 hour ago | finance.yahoo.comCardlytics (CDLX) Q2 Users Jump 19%August 7 at 2:00 AM | fool.comTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...August 9 at 2:00 AM | InvestorPlace (Ad)Cardlytics Reports Q2 2025 Financial ResultsAugust 6 at 12:39 AM | tipranks.comCardlytics, Inc. (CDLX) Q2 2025 Earnings Call TranscriptAugust 6 at 9:03 PM | seekingalpha.comCardlytics Announces Second Quarter 2025 Financial ResultsAugust 6 at 4:05 PM | businesswire.comCardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | businesswire.comHy-Vee's RedMedia Joins the Rippl Retail Media NetworkJuly 30, 2025 | tmcnet.comSee More Headlines CDLX Stock Analysis - Frequently Asked Questions How have CDLX shares performed this year? Cardlytics' stock was trading at $3.71 at the beginning of 2025. Since then, CDLX shares have decreased by 68.2% and is now trading at $1.18. How were Cardlytics' earnings last quarter? Cardlytics, Inc. (NASDAQ:CDLX) announced its earnings results on Wednesday, August, 6th. The company reported ($0.18) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by $0.02. The firm earned $63.25 million during the quarter, compared to analyst estimates of $64.06 million. Cardlytics had a negative trailing twelve-month return on equity of 279.39% and a negative net margin of 68.87%. Read the conference call transcript. Does Cardlytics have any subsidiaries? Cardlytics subsidiaries include these companies: Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited. When did Cardlytics IPO? Cardlytics (CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers. Who are Cardlytics' major shareholders? Cardlytics' top institutional shareholders include Lane Generational LLC (1.49%), Geode Capital Management LLC (1.20%), Acorn Financial Advisory Services Inc. ADV (0.62%) and Wolverine Asset Management LLC. Insiders that own company stock include Clifford Sosin, Karim Saad Temsamani, Amit Gupta, Scott D Grimes, Alexis Desieno, Nicholas Hollmeyer Lynton, Andrew Christiansen and John V Balen. View institutional ownership trends. How do I buy shares of Cardlytics? Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cardlytics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS). Company Calendar Last Earnings8/06/2025Today8/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Technology Services Sub-IndustryComputer Software Current SymbolNASDAQ:CDLX CIK1666071 Webwww.cardlytics.com Phone(888) 798-5802FaxN/AEmployees500Year Founded2008Price Target and Rating Average Price Target for Cardlytics$3.25 High Price Target$5.00 Low Price Target$2.00 Potential Upside/Downside+175.4%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($3.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$189.30 million Net Margins-68.87% Pretax Margin-68.87% Return on Equity-279.39% Return on Assets-48.17% Debt Debt-to-Equity Ratio2.87 Current Ratio1.16 Quick Ratio1.19 Sales & Book Value Annual Sales$278.30 million Price / Sales0.23 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / Book1.07Miscellaneous Outstanding Shares53,240,000Free Float50,192,000Market Cap$62.82 million OptionableOptionable Beta1.26 Social Links Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:CDLX) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardlytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardlytics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.